Enjoy complimentary customisation on priority with our Enterprise License!
The vascular patches market size has the potential to grow by USD 170.43 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by material (biologic vascular patches and synthetic vascular patches) and geography (North America, Europe, Asia, and ROW). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., CryoLife Inc., Getinge Group, Labcor Laboratorios LTDA, RTI Surgical Holdings Inc., Terumo Corp., and W. L. Gore & Associates Inc.
Browse TOC and LoE with selected illustrations and example pages of Vascular Patches Market
The market is fragmented. The key vendors in the market are focusing on R&D activities to increase their market share and expand their regional base. Abbott Laboratories, Baxter International Inc., and B. Braun Melsungen AG are some of the major market participants. Although the growing demand for biologic patches in vascular surgeries will offer immense growth opportunities, the complications and risks associated with vascular patches and vascular surgeries will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this vascular patches market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and offers information on the products offered by various companies. Moreover, this vascular patches market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
Request for a FREE sample and Get more information on the market contribution of various segments
Biologic vascular patches are made from biologic materials and are used widely for carotid endarterectomy procedures. These patches showed improved outcomes, as they provide better handling to the surgeon when compared with synthetic and vein patches. Furthermore, the rate of restenosis is significantly lesser than the synthetic vascular patches, which is likely to fuel the demand for this segment. In addition, the biologic vascular patches show extended durability, which will reduce the intraoperative suture line bleeding significantly. These factors are increasing the demand for biologic vascular patches, which, in turn, drives the market growth
Market growth in this segment will be slower than the growth of the market in the synthetic vascular patches segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the vascular patches market size.
For more insights on the market share of various regions Request for a FREE sample now!
North America was the largest vascular patches market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The presence of major vendors in the region, the increasing demand for minimally invasive surgeries, and the availability of advanced synthetic and biologic vascular patches will significantly drive vascular patches market growth in this region over the forecast period.
49% of the market's growth will originate from North America during the forecast period. The US is one of the key markets for vascular patches in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.
There is a growing demand for biologic patches that offer benefits such as durability, off-shelf availability, biocompatibility properties. Biologic patches are made of biomaterials such as amnion, decellularized human pericardium, decellularized bovine inferior vena cava, and bovine pericardium. When compared to synthetic patches, biologic patches have shown a significant reduction in intraoperative suture line bleeding. The growing demand for biologic patches will fuel vascular patches market growth during the forecast period.
Increasing R&D investments and product launches will be key vascular patches market trends that will positively impact market growth. Vascular patches manufacturers are investing huge amounts in research activities and this will result in the introduction of new products. For instance, LeMaitre Vascular has already made huge investments in R&D activities to enhance its existing product lines. With rising R&D investments and increasing demand for biologic patches, vascular patches market growth will accelerate at a CAGR of almost 8% during 2020-2024.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Material
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.